Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023

Stock Price vs Company Growth
1d
2.0%
1w
2.7%
1m
9.7%
3m
16.2%
6m
9.0%
1y
7.5%
all
27.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

2,213 2.0%
2,128
3,050
Company Overview

Sales
11,641 Cr
Growth: 14.8%
Profit after Tax
2,041 Cr
Growth: -3.5%
Large Cap
91,287 Cr
P/E: 43.4x
Industry P/E: 30.0x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 11,641
Growth 14.8%
EBITDA 25.4%
P/S 7.8x
Dividend 0.0%
P/E 43.4x
Book Value ₹ 265
PEG Ratio 2.9x
ROE 20.0%
P/B 8.2x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Followers (2)